发明名称 |
ANALYSIS OF SACCHARIDE VACCINES WITHOUT INTERFERENCE |
摘要 |
The invention provides two batches of a vaccine, wherein: (a) each of the batches of vaccine comprises: a conjugate of a capsular saccharide from serogroup C of Neisseria meningitidis and one or both of: (i) a conjugate of a capsular saccharide from serogroup W135 of Neisseria meningitidis; and/or (ii) a conjugate of a capsular saccharide from serogroup Y of Neisseria meningitidis; (b) the concentration of conjugated serogroup C saccharide in the first batch is C1; (c) the concentration of conjugated serogroup C saccharide in the second batch is C2; if applicable, (d) the concentration of conjugated serogroup W135 saccharide in the first batch is W1; if applicable, (e) the concentration of conjugated serogroup W135 saccharide in the second batch is W2; if applicable, (f) the concentration of conjugated serogroup Y saccharide in the first batch is Y1; if applicable, (g) the concentration of conjugated serogroup Y saccharide in the second batch is Y2; and wherein (h) the ratios C1/C2, W1/W2 and Y1/Y2 are each between 0.90 and 1.10. |
申请公布号 |
EP3035056(A1) |
申请公布日期 |
2016.06.22 |
申请号 |
EP20150192029 |
申请日期 |
2005.03.17 |
申请人 |
GLAXOSMITHKLINE BIOLOGICALS S.A. |
发明人 |
BARDOTTI, ANGELA;PROIETTI, DANIELA;RICCI, STEFANO |
分类号 |
G01N33/548;A61K39/00;A61K39/095;G01N30/02;G01N33/53;G01N33/569;G01N33/66 |
主分类号 |
G01N33/548 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|